SU Bernard J. Dunn School of Pharmacy Faculty Participate In Drug Research With George Washington University Faculty
Arthur Harralson, PharmD, associate dean for research, and Robert Kidd, PharmD, Ph.D., professor of biopharmaceutical sciences, from Shenandoah University’s Bernard J. Dunn School of Pharmacy will participate in a research study led by The George Washington University (GWU) Pharmacologist Travis O’Brien, Ph.D., and a multidisciplinary team of physicians and health economists, to investigate how the drug warfarin, an oral anticoagulant used to treat individuals with cardiovascular diseases, can be personalized based on a patient’s individual genomic biomarkers.
The multidisciplinary research team also includes GWU’s April Barbour, M.D., assistant professor of medicine, Linda Lesky, M.D., associate professor of medicine and health policy, and Perry Payne Jr., M.D., J.D., M.P.P., assistant research professor of health policy.
"The multidisciplinary team of physicians and health economists will investigate how the drug warfarin, an oral anticoagulant used to treat individuals with cardiovascular diseases, can be personalized based on a patient’s individual genomic biomarkers," said Bernard J. Dunn School of Pharmacy Dean Alan McKay.